Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas (beijing) Pharmaceutical R&d Co., Ltd.

Clinical trials sponsored by Astellas (beijing) Pharmaceutical R&d Co., Ltd., explained in plain language.

Not yet finished but already full! 1

New drug combo shows promise for chinese men with advanced prostate cancer

Disease control Ongoing

This phase 3 study tested whether adding enzalutamide (Xtandi) to standard hormone therapy (ADT) helps Chinese men with metastatic hormone-sensitive prostate cancer. 180 participants received either enzalutamide plus ADT or a placebo plus ADT. The main goal was to see how long it…

Phase: PHASE3 • Sponsor: Astellas (Beijing) Pharmaceutical R&D Co., Ltd. • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC